Literature DB >> 20060831

Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States.

Constance E Ruhl1, James E Everhart.   

Abstract

BACKGROUND & AIMS: Liver injury is associated with obesity and related measures, such as body mass index (BMI) and waist circumference. The relationship between liver injury and body composition has not been evaluated in a population-based study.
METHODS: Using data from a US population-based survey, we examined the contributions of body composition, measured by dual-energy x-ray absorptiometry (DXA), to increased serum alanine aminotransferase (ALT) activity among 11,821 adults without viral hepatitis. Trunk fat, extremity fat, trunk lean, and extremity lean mass were divided by height squared and used to categorize subjects into quintiles; logistic regression odds ratios (OR) were calculated for increased ALT.
RESULTS: Increased ALT was associated with higher measures of fat and lean mass (P < .001) after adjustment for alcohol consumption and other liver injury risk factors in separate models for each DXA measure. Trunk fat was associated with increased ALT (P < or = .001) in models also including any 1 of the other 3 measures. Extremity fat was independently inversely associated among women (P < .001). Trunk and extremity lean mass were not independently related to increased ALT. In models that contained all 4 DXA measures, the OR (95% confidence interval [CI]) for increased ALT for the highest, relative to lowest, quintile of trunk fat/height squared was 13.8 (95% CI: 5.4-35.3) for men and 7.8 (95% CI: 3.9-15.8) for women. When BMI, waist circumference, and trunk fat were considered together, only trunk fat remained independently associated with increased ALT.
CONCLUSIONS: Trunk fat is a major body composition determinant of increased ALT, supporting the hypothesis that liver injury can be induced by metabolically active intraabdominal fat. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  National Health and Nutrition Examination Survey; alanine aminotransferase; body composition; dual-energy x-ray absorptiometry

Mesh:

Substances:

Year:  2010        PMID: 20060831      PMCID: PMC2847039          DOI: 10.1053/j.gastro.2009.12.053

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

1.  Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status.

Authors:  T B VanItallie; M U Yang; S B Heymsfield; R C Funk; R A Boileau
Journal:  Am J Clin Nutr       Date:  1990-12       Impact factor: 7.045

2.  Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study.

Authors:  Isabel Ferreira; Marieke B Snijder; Jos W R Twisk; Willem van Mechelen; Han C G Kemper; Jacob C Seidell; Coen D A Stehouwer
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

3.  Regional fat distribution in women and risk of cardiovascular disease.

Authors:  M J Williams; G R Hunter; T Kekes-Szabo; S Snyder; M S Treuth
Journal:  Am J Clin Nutr       Date:  1997-03       Impact factor: 7.045

4.  Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM.

Authors:  M A Banerji; M C Buckley; R L Chaiken; D Gordon; H E Lebovitz; J G Kral
Journal:  Int J Obes Relat Metab Disord       Date:  1995-12

5.  Body fat topography as an independent predictor of fatty liver.

Authors:  J G Kral; F Schaffner; R N Pierson; J Wang
Journal:  Metabolism       Date:  1993-05       Impact factor: 8.694

6.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

7.  Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation.

Authors:  M Rebuffé-Scrive; L Enk; N Crona; P Lönnroth; L Abrahamsson; U Smith; P Björntorp
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

8.  Splanchnic lipolysis in human obesity.

Authors:  Soren Nielsen; ZengKui Guo; C Michael Johnson; Donald D Hensrud; Michael D Jensen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

9.  Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk.

Authors:  J Westerbacka; A Cornér; M Tiikkainen; M Tamminen; S Vehkavaara; A-M Häkkinen; J Fredriksson; H Yki-Järvinen
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

10.  Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.

Authors:  Naga Chalasani; Mark A Deeg; Scott Persohn; David W Crabb
Journal:  Am J Gastroenterol       Date:  2003-08       Impact factor: 10.864

View more
  30 in total

1.  HLA DQB1 alleles are related with nonalcoholic fatty liver disease.

Authors:  Levent Doganay; Seyma Katrinli; Yasar Colak; Ebubekir Senates; Ebru Zemheri; Oguzhan Ozturk; Feruze Yilmaz Enc; Ilyas Tuncer; Gizem Dinler Doganay
Journal:  Mol Biol Rep       Date:  2014-08-26       Impact factor: 2.316

2.  Impact of weight-loss surgery and diabetes status on serum ALT levels.

Authors:  Dimitrios Xourafas; Ali Ardestani; Stanley W Ashley; Ali Tavakkoli
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

3.  The association of low serum alanine aminotransferase activity with mortality in the US population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Am J Epidemiol       Date:  2013-09-26       Impact factor: 4.897

4.  Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice.

Authors:  Sanjaya K Satapathy; Mahendar Ochani; Meghan Dancho; Laqueta K Hudson; Mauricio Rosas-Ballina; Sergio I Valdes-Ferrer; Peder S Olofsson; Yael Tobi Harris; Jesse Roth; Sangeeta Chavan; Kevin J Tracey; Valentin A Pavlov
Journal:  Mol Med       Date:  2011-07-01       Impact factor: 6.354

5.  Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology.

Authors:  Waleed Al-hamoudi; Safiyya Ali; Bassem Hegab; Hussien Elsiesy; Almoutaz Hashim; Mohammed Al-Sofayan; Hatem Khalaf; Hamad Al-Bahili; Nasser Al-Masri; Mohammed Al-Sebayel; Dieter Broering; Ayman Abdo; Saleh Alqahtani; Faisal Abaalkhail
Journal:  Dig Dis Sci       Date:  2013-03-30       Impact factor: 3.199

6.  Trunk fat as a determinant of liver disease.

Authors:  Jacquelyn J Maher
Journal:  Gastroenterology       Date:  2010-02-23       Impact factor: 22.682

7.  Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.

Authors:  James Tsai; Earl S Ford; Guixiang Zhao; Chaoyang Li; Kurt J Greenlund; Janet B Croft
Journal:  J Behav Med       Date:  2011-05-28

8.  Body composition, hemodynamic, and biochemical parameters of young female normal-weight oligo-amenorrheic and eumenorrheic athletes and nonathletes.

Authors:  Vibha Singhal; Maria de Lourdes Eguiguren; Lindsey Eisenbach; Hannah Clarke; Meghan Slattery; Kamryn Eddy; Kathryn E Ackerman; Madhusmita Misra
Journal:  Ann Nutr Metab       Date:  2014-10-31       Impact factor: 3.374

9.  The association between serum liver enzymes and cancer mortality.

Authors:  Somaya Albhaisi; Rehan Qayyum
Journal:  Clin Exp Med       Date:  2021-07-08       Impact factor: 3.984

10.  Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

Authors:  Heriberto Rodríguez-Hernández; Luis E Simental-Mendía; Gabriela Rodríguez-Ramírez; Miguel A Reyes-Romero
Journal:  Int J Endocrinol       Date:  2013-04-17       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.